InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,864.67
(
0.40%
)
US TECH 100
19,783.20
(
0.68%
)
Dow Jones
43,275.91
(
0.09%
)
Brent Oil
72.94
(
0.00%
)
Bitcoin
68,718.66
(
0.52%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rancherho

Send PM Follow Ignore
Followers 8
Posts 190
Boards Moderated 0
Alias Born 10/30/2005

rancherho

Re: None

Thursday, 11/08/2007 2:06:02 PM

Thursday, November 08, 2007 2:06:02 PM

Post# of 12660
Gleasons score was not among the 10 independent factors found to be prognostic for survival in a new study which developed a nomogram based on patients in the Taxotere TAX327 pivotal Ph 3 trial.A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis
Clinical Cancer Research 13, 6396-6403, November 1, 2007. doi: 10.1158/1078-0432.CCR-07-1036
http://clincancerres.aacrjournals.org/cgi/content/full/13/21/6396
The median survival of the worst quartile studied was about 13.8 months and of the best quartile was about 24.7 months.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up